Press releases
-
ICON Reports Fourth Quarter and Full Year 2018 Results
Full year reported revenue was $2,595.8 million. Excluding the impact of ASC 606, full year revenue increased to $1,897.6 million from $1,758.4 million in 2017, an increase of 7.9%. -
ICON Launches New Drug Safety Reporting Solution Ensuring Compliance Through Automation
Developed on platform deploying rule-based automation for timely delivery of drug safety information. -
-
-
ICON wins Pharma Contract Services Company of the Year at the Pharma Industry Awards 2018
The Pharma Industry Awards recognise and celebrate innovative individuals and companies that demonstrate excellence in the Irish Pharma sector -
-
-
-
ICON and DIA driving Insights to Action with DIA Live 2018
Social media aggregation site will highlight real-time digital conversations at DIA 2018 -
ICON enhances Endpoint Adjudication Services
Agreement to use Judi, a comprehensive electronic endpoint adjudication system to manage workflow and ensure data quality
